Thank you very much, Mr. Chair.
I will try to be as brief as possible.
We've heard from witnesses that the use of data in informing health policy is quite useful, as it's balanced. We've also heard from witnesses that there is no perfect process by which we can maintain that transparency.
In your paper discussing the harm reduction approach and the ethical management of the COVID-19 pandemic, one of the principles that you apply this to is optimizing the use of space and time. Would you agree that mobility data would help increase the efficiency of protecting the public and making sure that there's a finer balance between restrictions and privacy?